Tebentafusp
Cat. No.: IBDI-432111
Tebentafusp (IMCgp100) is a bispecific fusion protein to target gp100 peptide-HLA-A*02:01 (a melanoma-associated antigen). Tebentafusp guides T cells to kill gp100-expressing tumor cells via a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain. Tebentafusp leads to inflammatory cytokines and cytolytic proteins production, resulting in the direct lysis of tumour cells.
Product Details
Target |
Interleukin Related | TNF Receptor |
Appearance |
Liquid |
Synonyms |
IMCgp100 |
SMILES |
[Tebentafusp] |
Purity |
98.00% |
Storage & Handling
Shipping |
Shipping with dry ice. |
Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.